Tag: University of Michigan
-
Histotripsy grants tripled to 12 in 2025, and Michigan plus its $2.25B spinout HistoSonics hold 83% of them. The mechanism is now migrating from liver tumors to the immune system.
-
Histotripsy noninvasively liquefies tumors with cavitation bubbles — and the antigens it releases are training the immune system to find tumors the transducer never touched.